Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
23 Jul 2014 MED12 Somatic Mutations in Breast Fibroadenoma Translational research
21 Jul 2014 Acquired Resistance to Tyrosine Kinase Inhibitors in Solid Tumours Lung and other thoracic tumours - Anticancer agents & Biologic therapy
18 Jul 2014 Prostate Cancer in Young Men Genitourinary cancers
17 Jul 2014 CLARINET Study in Metastatic Enteropancreatic NETs Published in the New England Journal of Medicine Endocrine cancers - Anticancer agents & Biologic therapy
16 Jul 2014 MEK Inhibitors Melanoma - Anticancer agents & Biologic therapy
15 Jul 2014 Sinonasal Cancers Head and neck cancers
14 Jul 2014 Molecular Profiling of Lung Adenocarcinoma Pathology/Molecular biology - Translational research - Lung and other thoracic tumours
10 Jul 2014 Nivolumab Receives Manufacturing and Marketing Approval in Japan for the Treatment of Unresectable Melanoma Melanoma - Cancer Immunology and Immunotherapy
09 Jul 2014 FDA Approves Belinostat to Treat Patients with Peripheral T-cell Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
08 Jul 2014 Is There an Expanding Role of Hepatic Resection for Melanoma? Melanoma
07 Jul 2014 EORTC Proposes the Use of Collaborative Molecular Screening Platforms Personalised medicine - Pathology/Molecular biology - Anticancer agents & Biologic therapy
04 Jul 2014 Comprehensive Review of Treatments for Depression in Cancer Patients Palliative and supportive care
03 Jul 2014 Withdrawal of the Application for a Change to the Marketing Authorisation for Nilotinib Haematologic malignancies - Anticancer agents & Biologic therapy
02 Jul 2014 FDA Approves Lymphoseek for Determining the Extent of Squamous Cell Carcinoma of the Oral Cavity Imaging - Head and neck cancers
01 Jul 2014 World GI: CONCUR Study Shows Improvement in Survival Outcomes with Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy